CRISTIANO, GIANLUCA
CRISTIANO, GIANLUCA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Dottorandi
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure
2023 Sartor C.; Brunetti L.; Audisio E.; Cignetti A.; Zannoni L.; Cristiano G.; Nanni J.; Ciruolo R.; Zingarelli F.; Ottaviani E.; Patuelli A.; Bandini L.; Forte D.; Sciabolacci S.; Cardinali V.; Papayannidis C.; Cavo M.; Martelli M.P.; Curti A.
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study
2023 Liu, Chun; Cojutti, Pier Giorgio; Giannella, Maddalena; Roberto, Marcello; Casadei, Beatrice; Cristiano, Gianluca; Papayannidis, Cristina; Vianelli, Nicola; Zinzani, Pier Luigi; Viale, Pierluigi; Bonifazi, Francesca; Pea, Federico
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study
2023 Marconi G.; Candoni A.; Di Nicola R.; Sartor C.; Parisi S.; Abbenante M.; Nanni J.; Cristiano G.; Zannoni L.; Lazzarotto D.; Giannini B.; Baldazzi C.; Bandini L.; Ottaviani E.; Testoni N.; Bezzi C.D.G.; Abd-alatif R.; Ciotti G.; Fanin R.; Martinelli G.; Paolini S.; Ricci P.; Cavo M.; Papayannidis C.; Curti A.
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia
2022 Ragaini S.; Wagner S.; Marconi G.; Parisi S.; Sartor C.; Nanni J.; Cristiano G.; Talami A.; Olivi M.; Ocadlikova D.; Ciciarello M.; Corradi G.; Ottaviani E.; Papayannidis C.; Paolini S.; Vadakekolathu J.; Cavo M.; Rutella S.; Curti A.
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia
2022 Ravaioli F.; Marconi G.; Martinelli G.; Dajti E.; Sartor C.; Abbenante M.C.; Alemanni L.V.; Nanni J.; Rossini B.; Parisi S.; Colecchia L.; Cristiano G.; Marasco G.; Vestito A.; Paolini S.; Bonifazi F.; Curti A.; Festi D.; Cavo M.; Colecchia A.; Papayannidis C.
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment
2022 Sartor C.; Arpinati M.; Chirumbolo G.; Dozza L.; Cristiano G.; Nanni J.; Marconi G.; Robustelli V.; Vigliotta I.; Parisi S.; Terragna C.; Testoni N.; Paolini S.; Martinelli G.; Curti A.; Cavo M.; Papayannidis C.
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents
2022 Papayannidis C.; Nanni J.; Cristiano G.; Marconi G.; Sartor C.; Parisi S.; Zannoni L.; Saed R.; Ottaviani E.; Bandini L.; Testoni N.; Baldazzi C.; Solli V.; Ricci P.; Di Giovanni Bezzi C.; Abd-alatif R.; Stanzani M.; Paolini S.; Cavo M.; Curti A.
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
2022 Parisi, Sarah; Ruggeri, Loredana; Dan, Elisa; Rizzi, Simonetta; Sinigaglia, Barbara; Ocadlikova, Darina; Bontadini, Andrea; Giudice, Valeria; Urbani, Elena; Ciardelli, Sara; Sartor, Chiara; Cristiano, Gianluca; Nanni, Jacopo; Zannoni, Letizia; Chirumbolo, Gabriella; Arpinati, Mario; Lewis, Russell E.; Bonifazi, Francesca; Marconi, Giovanni; Martinelli, Giovanni; Papayannidis, Cristina; Paolini, Stefania; Velardi, Andrea; Cavo, Michele; Lemoli, Roberto M.; Curti, Antonio
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
2022 Parisi S.; Ruggeri L.; Dan E.; Rizzi S.; Sinigaglia B.; Ocadlikova D.; Bontadini A.; Giudice V.; Urbani E.; Ciardelli S.; Sartor C.; Cristiano G.; Nanni J.; Zannoni L.; Chirumbolo G.; Arpinati M.; Lewis R.E.; Bonifazi F.; Marconi G.; Martinelli G.; Papayannidis C.; Paolini S.; Velardi A.; Cavo M.; Lemoli R.M.; Curti A.
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells
2022 Corradi G.; Bassani B.; Simonetti G.; Sangaletti S.; Vadakekolathu J.; Fontana M.C.; Pazzaglia M.; Gulino A.; Tripodo C.; Cristiano G.; Bandini L.; Ottaviani E.; Ocadlikova D.; Piccioli M.; Martinelli G.; Colombo M.P.; Rutella S.; Cavo M.; Ciciarello M.; Curti A.
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia
2021 Bruno S.; Bandini L.; Patuelli A.; Robustelli V.; Venturi C.; Mancini M.; Forte D.; De Santis S.; Monaldi C.; Grassi A.; Chiurumbolo G.; Paolini S.; Cristiano G.; Papayannidis C.; Sartor C.; Nanni J.; Ottaviani E.; Curti A.; Cavo M.; Soverini S.
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement
2021 Cristiano G.; Nanni J.; Sartor C.; Parisi S.; Marconi G.; Barbato F.; Arpinati M.; Bonifazi F.; Curti A.; Cavo M.; Paolini S.; Papayannidis C.
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant
2021 Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nanni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F.
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients
2021 Marconi G.; De Polo S.; Martinelli G.; Nanni J.; Bertamini L.; Talami A.; Olivi M.; Ragaini S.; Abbenante M.C.; Sartor C.; Ottaviani E.; Bochicchio M.T.; Parisi S.; Fontana M.C.; Cristiano G.; Raffini M.; Baldazzi C.; Testoni N.; Bonifazi F.; Paolini S.; Curti A.; Cavo M.; Papayannidis C.
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia
2020 Marconi G.; Talami A.; Abbenante M.C.; Sartor C.; Parisi S.; Nanni J.; Bertamini L.; Ragaini S.; Olivi M.; de Polo S.; Cristiano G.; Fontana M.C.; Bochicchio M.T.; Ottaviani E.; Arpinati M.; Sessa M.; Baldazzi C.; Caso L.; Testoni N.; Baccarani M.; Bonifazi F.; Martinelli G.; Paolini S.; Cavo M.; Papayannidis C.; Curti A.
Acute myeloid leukemia mutations: Therapeutic implications
2019 Papayannidis C.; Sartor C.; Marconi G.; Fontana M.C.; Nanni J.; Cristiano G.; Parisi S.; Paolini S.; Curti A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure | Sartor C.; Brunetti L.; Audisio E.; Cignetti A.; Zannoni L.; Cristiano G.; Nanni J.; Ciruolo R.; ...Zingarelli F.; Ottaviani E.; Patuelli A.; Bandini L.; Forte D.; Sciabolacci S.; Cardinali V.; Papayannidis C.; Cavo M.; Martelli M.P.; Curti A. | 2023-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | Br J Haematol - 2023 - Sartor - A venetoclax and azacitidine bridge‐to‐transplant strategy for NPM1‐mutated acute myeloid.pdf; bjh18887-sup-0001-figures1-s2.docx |
| Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study | Liu, Chun; Cojutti, Pier Giorgio; Giannella, Maddalena; Roberto, Marcello; Casadei, Beatrice; Cri...stiano, Gianluca; Papayannidis, Cristina; Vianelli, Nicola; Zinzani, Pier Luigi; Viale, Pierluigi; Bonifazi, Francesca; Pea, Federico | 2023-01-01 | PHARMACEUTICS | - | 1.01 Articolo in rivista | pharmaceutics-15-01022.pdf |
| The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study | Marconi G.; Candoni A.; Di Nicola R.; Sartor C.; Parisi S.; Abbenante M.; Nanni J.; Cristiano G.;... Zannoni L.; Lazzarotto D.; Giannini B.; Baldazzi C.; Bandini L.; Ottaviani E.; Testoni N.; Bezzi C.D.G.; Abd-alatif R.; Ciotti G.; Fanin R.; Martinelli G.; Paolini S.; Ricci P.; Cavo M.; Papayannidis C.; Curti A. | 2023-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | CANCER~1.PDF; CAM4-12-11838-s001.docx |
| An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia | Ragaini S.; Wagner S.; Marconi G.; Parisi S.; Sartor C.; Nanni J.; Cristiano G.; Talami A.; Olivi... M.; Ocadlikova D.; Ciciarello M.; Corradi G.; Ottaviani E.; Papayannidis C.; Paolini S.; Vadakekolathu J.; Cavo M.; Rutella S.; Curti A. | 2022-01-01 | BLOOD ADVANCES | - | 1.01 Articolo in rivista | IDO1 score Ragaini Blood Advances.pdf; advancesADV2021004878-suppl1.pdf |
| Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia | Ravaioli F.; Marconi G.; Martinelli G.; Dajti E.; Sartor C.; Abbenante M.C.; Alemanni L.V.; Nanni... J.; Rossini B.; Parisi S.; Colecchia L.; Cristiano G.; Marasco G.; Vestito A.; Paolini S.; Bonifazi F.; Curti A.; Festi D.; Cavo M.; Colecchia A.; Papayannidis C. | 2022-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Cancer Medicine - 2022 - Ravaioli - Assessment of liver stiffness measurement and ultrasound findings change during.pdf; CAM4-11-618-s005.zip |
| Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment | Sartor C.; Arpinati M.; Chirumbolo G.; Dozza L.; Cristiano G.; Nanni J.; Marconi G.; Robustelli V....; Vigliotta I.; Parisi S.; Terragna C.; Testoni N.; Paolini S.; Martinelli G.; Curti A.; Cavo M.; Papayannidis C. | 2022-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents | Papayannidis C.; Nanni J.; Cristiano G.; Marconi G.; Sartor C.; Parisi S.; Zannoni L.; Saed R.; O...ttaviani E.; Bandini L.; Testoni N.; Baldazzi C.; Solli V.; Ricci P.; Di Giovanni Bezzi C.; Abd-alatif R.; Stanzani M.; Paolini S.; Cavo M.; Curti A. | 2022-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | EJH-108-449.pdf; EJH-108-449-s001.docx |
| Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters | Parisi, Sarah; Ruggeri, Loredana; Dan, Elisa; Rizzi, Simonetta; Sinigaglia, Barbara; Ocadlikova, ...Darina; Bontadini, Andrea; Giudice, Valeria; Urbani, Elena; Ciardelli, Sara; Sartor, Chiara; Cristiano, Gianluca; Nanni, Jacopo; Zannoni, Letizia; Chirumbolo, Gabriella; Arpinati, Mario; Lewis, Russell E.; Bonifazi, Francesca; Marconi, Giovanni; Martinelli, Giovanni; Papayannidis, Cristina; Paolini, Stefania; Velardi, Andrea; Cavo, Michele; Lemoli, Roberto M.; Curti, Antonio | 2022-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | frontiers in immunology.pdf |
| Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters | Parisi S.; Ruggeri L.; Dan E.; Rizzi S.; Sinigaglia B.; Ocadlikova D.; Bontadini A.; Giudice V.; ...Urbani E.; Ciardelli S.; Sartor C.; Cristiano G.; Nanni J.; Zannoni L.; Chirumbolo G.; Arpinati M.; Lewis R.E.; Bonifazi F.; Marconi G.; Martinelli G.; Papayannidis C.; Paolini S.; Velardi A.; Cavo M.; Lemoli R.M.; Curti A. | 2022-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | Parisi et al. 2021 - Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells - Alloreactive NK Cell Dose Still Matters.pdf |
| Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells | Corradi G.; Bassani B.; Simonetti G.; Sangaletti S.; Vadakekolathu J.; Fontana M.C.; Pazzaglia M....; Gulino A.; Tripodo C.; Cristiano G.; Bandini L.; Ottaviani E.; Ocadlikova D.; Piccioli M.; Martinelli G.; Colombo M.P.; Rutella S.; Cavo M.; Ciciarello M.; Curti A. | 2022-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia | Bruno S.; Bandini L.; Patuelli A.; Robustelli V.; Venturi C.; Mancini M.; Forte D.; De Santis S.;... Monaldi C.; Grassi A.; Chiurumbolo G.; Paolini S.; Cristiano G.; Papayannidis C.; Sartor C.; Nanni J.; Ottaviani E.; Curti A.; Cavo M.; Soverini S. | 2021-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-11-728613.pdf |
| Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement | Cristiano G.; Nanni J.; Sartor C.; Parisi S.; Marconi G.; Barbato F.; Arpinati M.; Bonifazi F.; C...urti A.; Cavo M.; Paolini S.; Papayannidis C. | 2021-01-01 | ACTA HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant | Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nan...ni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F. | 2021-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients | Marconi G.; De Polo S.; Martinelli G.; Nanni J.; Bertamini L.; Talami A.; Olivi M.; Ragaini S.; A...bbenante M.C.; Sartor C.; Ottaviani E.; Bochicchio M.T.; Parisi S.; Fontana M.C.; Cristiano G.; Raffini M.; Baldazzi C.; Testoni N.; Bonifazi F.; Paolini S.; Curti A.; Cavo M.; Papayannidis C. | 2021-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia | Marconi G.; Talami A.; Abbenante M.C.; Sartor C.; Parisi S.; Nanni J.; Bertamini L.; Ragaini S.; ...Olivi M.; de Polo S.; Cristiano G.; Fontana M.C.; Bochicchio M.T.; Ottaviani E.; Arpinati M.; Sessa M.; Baldazzi C.; Caso L.; Testoni N.; Baccarani M.; Bonifazi F.; Martinelli G.; Paolini S.; Cavo M.; Papayannidis C.; Curti A. | 2020-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Acute myeloid leukemia mutations: Therapeutic implications | Papayannidis C.; Sartor C.; Marconi G.; Fontana M.C.; Nanni J.; Cristiano G.; Parisi S.; Paolini ...S.; Curti A. | 2019-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | - |